Elise R A Pennings

9PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Science, technology and engineering curriculum and pedagogyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

|Mar 09, 2026
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies.

Elise R A Pennings, Frederick W Thielen, Florence Broussais

|Sep 25, 2025
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Florence Broussais, Elise Pennings, Natacha Bolanos

|Jan 04, 2024
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.

Elise R A Pennings, Müjde Durmaz, Otto Visser

|Nov 25, 2023
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.

Janneke W de Boer, Kylie Keijzer, Elise R A Pennings

|Sep 09, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.

Anne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers

Pageof 2

Frequent Collaborators

6 joint publications

Marie Jose Kersten

5 joint publications

Tom van Meerten

5 joint publications

Joost S P Vermaat

4 joint publications

Margot Jak